INS and Alzheimer disease: As shown in Fig. 2, our serum analysis data revealed a substantial increase (p < 0.0001) in HbA1c, glucose levels, insulin, and insulin resistance (HOMA-IR) in the AD model group (G4) in contrast to the control group (G1).